Contact Us
Environment
News
Careers
Home
About Us
Our Products
Manufacturing
Sales
NHS
Aspirin may fight cancer by slowing DNA damage
|
MedImmune, AstraZeneca's biologics arm, and NGM Biopharmaceuticals announce agreement to discover and develop therapies for diabetes and obesity
|
FDA approves Amgen's XGEVA® (denosumab) for the treatment of giant cell tumor of bone
|
Bristol-Myers Squibb and Simcere enter partnership to co-develop and co-commercialize Orencia® SC (abatacept) in China
|
Pfizer obtains $2.15 billion settlement from Teva and Sun for infringement of Protonix® patent
|
Diabetes drug points the way to overcoming drug resistance in melanoma
|
New four-strain influenza vaccine from Sanofi Pasteur now licensed by FDA
|
AstraZeneca to acquire Pearl Therapeutics to strengthen respiratory portfolio
|
Investigation into safety of new diabetes drugs
|
Boehringer Ingelheim pioneers biopharmaceuticals move to China
|
Big multiple sclerosis breakthrough
|
FDA grants Priority Review to Bristol-Myers Squibb and AstraZeneca's Metreleptin
|
Musculoskeletal conditions, injuries may be associated with statin use
|
Sanofi provides update on Phase 3 studies of two investigational compounds
|
MyHealthAvatar Survey: Your Opinion Counts
|
Double dose of antiviral drug offers no added benefit in severe influenza
|
Amgen and Astellas announce Japan Alliance
|
Novartis launches a new campaign to raise awareness of MS
|
AstraZeneca to acquire Omthera Pharmaceuticals including NDA-ready novel dyslipidemia treatment to complement cardiovascular portfolio
|
Researchers identify first drug targets in childhood genetic tumor disorder
|
Products
Kent Label
Fannin
Generics
P.I.s
UK Packs
OTC
Dressings and Surgicals
Anaesthetics
Special Services
Early Bird
Safe-Inject
Dressings
and Surgicals
a
b
c
d
e
f
g
h
i
j
k
l
m
n
o
p
q
r
s
t
u
v
w
x
y
z
Code
Description
Strength
Pack
PIL
SPC
No matching products, please try again.
